CASE DISCUSSION
Type 2 Diabetes in Adolescents: A Growing Epidemic
Presented from by Dr. Sadaf Siddiqui
0
Likes
1678
Views
67
Shares
0
Bookmarks
0
Credit Points
0
Learning Hours
0
CPD/CME Points
0
Courses Completed
Case Description
Type 2 Diabetes in adolescents is emerging as a significant public health concern, driven largely by rising obesity rates and sedentary lifestyles. Unlike type 1 diabetes, it is increasingly diagnosed in younger populations due to poor dietary habits and reduced physical activity. Early onset poses...
Case Summary
- Type 2 diabetes incidence is projected to increase significantly worldwide by 2050, particularly in Africa and the Middle East, accompanied by substantial financial investment and increased mortality/morbidity. This rise is linked to the growing prevalence of childhood obesity, necessitating early recognition and intervention. Early-onset type 2 diabetes is clinically aggressive, leading to rapid beta cell decline and increased treatment failure rates, highlighting the need to differentiate it from slowly evolving type 1 diabetes.
Speaker Profile
Dr. Sadaf Siddiqui
Business & Operations Head, Rainbow Hospitals, BengaluruDr. Sadaf Siddiqui is a Specialist Pediatrician at Emirates Hospitals Group with over 7 years of experience in general pediatrics and expertise in Pediatric and Adolescent Endocrinology. Practicing at Emirates Hospitals Day Surgery Motor City, she is highly regarded for her compassionate care and clinical excellence. Dr. Siddiqui specializes in managing pediatric growth and pubertal disorders, thyroid issues, juvenile diabetes, obesity, and common pediatric conditions such as infections, allergies, and asthma. A Gold Medalist in Pediatrics from D.Y. Patil University, she also holds a Diploma in Infectious Diseases from the Royal College of Physicians, Ireland, and is a member of RCPI and the Indian Academy of Pediatrics.
Disclosures
Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.